Novel Meibomian Gland and Tarsal Conjunctival Changes Associated with Trastuzumab, Pertuzumab, and Anastrozole Treatment for Metastatic HER2 Positive Breast Cancer: A Case Report and Literature Review

The aim of the study was to report a case of severe meibomian gland dysfunction (MGD) and conjunctival changes associated with trastuzumab, pertuzumab, and anastrozole therapy in a HER-2 positive breast cancer patient. A 57-year-old white woman was treated with trastuzumab and pertuzumab biological...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Amarilla Barcsay-Veres, Anna Maria Tokes, Jeannette Toth, Zsuzsa Szilagyi, Eva Katalin Toth, Zoltan Z. Nagy, Anna Horvath
Format:	Artigo
Jezik:	Inglês
Izdano:	Karger Publishers 2022-05-01
Serija:	Case Reports in Oncology
Teme:	anti-her2 biological therapy anastrozole meibomian gland dysfunction her2+ breast cancer trastuzumab
Online dostop:	https://www.karger.com/Article/FullText/524176
Oznake:	Označite Brez oznak, prvi označite!